Cargando…

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching

INTRODUCTION: Current treatment with vasodilators for pulmonary hypertension associated with respiratory diseases is limited by their inhibitory effect on hypoxic pulmonary vasoconstriction (HPV) and uncoupling effects on ventilation-perfusion (V’/Q’). Hypoxia is also a well-known modulator of the n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamorro, Virginia, Morales-Cano, Daniel, Milara, Javier, Barreira, Bianca, Moreno, Laura, Callejo, María, Mondejar-Parreño, Gema, Esquivel-Ruiz, Sergio, Cortijo, Julio, Cogolludo, Ángel, Barberá, Joan A., Perez-Vizcaino, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783366/ https://www.ncbi.nlm.nih.gov/pubmed/29364918 http://dx.doi.org/10.1371/journal.pone.0191239

Ejemplares similares

Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K(+) Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency
por: Callejo, Maria, et al.
Publicado: (2021)

Elevated pulmonary arterial pressure in Zucker diabetic fatty rats
por: Morales-Cano, Daniel, et al.
Publicado: (2019)

Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021)

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
por: Callejo, María, et al.
Publicado: (2018)

Kv7 Channels in Lung Diseases
por: Mondejar-Parreño, Gema, et al.
Publicado: (2020)

Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2021)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension
por: Callejo, Maria, et al.
Publicado: (2020)

Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
por: Cogolludo, Angel, et al.
Publicado: (2009)

Optimization of isolated perfused/ventilated mouse lung to study hypoxic pulmonary vasoconstriction
por: Yoo, Hae Young, et al.
Publicado: (2013)

Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused/ventilated mouse lung
por: Jain, Pritesh P., et al.
Publicado: (2020)

Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2022)

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences
por: Andersen, Asger, et al.
Publicado: (2017)

Hypoxic Pulmonary Vasoconstriction in Humans
por: Ariyaratnam, Priyadharshanan, et al.
Publicado: (2013)

Integrative understanding of hypoxic pulmonary vasoconstriction using in vitro models: from ventilated/perfused lung to single arterial myocyte
por: Yoo, Hae Young, et al.
Publicado: (2014)

Hypoxic pulmonary vasoconstriction as a regulator of alveolar-capillary oxygen flux: A computational model of ventilation-perfusion matching
por: Marquis, Andrew D., et al.
Publicado: (2021)

Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling
por: Taran, Irina N., et al.
Publicado: (2018)

Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding
por: Rai, Nabham, et al.
Publicado: (2018)

HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction
por: Labrousse-Arias, David, et al.
Publicado: (2016)

Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth
por: Hussain, A., et al.
Publicado: (2017)

Mitochondrial transplantation attenuates hypoxic pulmonary vasoconstriction
por: Zhou, Juan, et al.
Publicado: (2016)

Sustained Hypoxic Pulmonary Vasoconstriction in the Isolated Perfused Rat Lung: Effect of α(1)-adrenergic Receptor Agonist
por: Ketabchi, Farzaneh, et al.
Publicado: (2014)

Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
por: Andersen, Asger
Publicado: (2018)

Inhibition of Hypoxic Pulmonary Vasoconstriction of Rats by Carbon Monoxide
por: Yoo, Hae Young, et al.
Publicado: (2010)

Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemia
por: Petersen, Bodil, et al.
Publicado: (2019)

Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
por: Rai, Nabham, et al.
Publicado: (2018)

Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction
por: Ketabchi, Farzaneh, et al.
Publicado: (2012)

Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels
por: Sweeney, Michèle, et al.
Publicado: (2000)

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
por: Gierhardt, Mareike, et al.
Publicado: (2021)

Dual role of the L-arginine–ADMA–NO pathway in systemic hypoxic vasodilation and pulmonary hypoxic vasoconstriction
por: Böger, Rainer, et al.
Publicado: (2020)

Heterogeneous Perfusion in COVID-19 and High Altitude Pulmonary Edema: A Review of Two Cases Followed by Implications for Hypoxic Pulmonary Vasoconstriction, Thrombosis Development, Ventilation Perfusion Mismatch and Emergence of Treatment Approaches
por: Solaimanzadeh, Isaac
Publicado: (2020)

Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery
por: Knock, Greg A., et al.
Publicado: (2008)

Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs
por: Hubloue, Ives, et al.
Publicado: (2004)

Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6
por: Fuchs, Beate, et al.
Publicado: (2011)

Role of ATP-sensitive potassium channels on hypoxic pulmonary vasoconstriction in endotoxemia
por: Turzo, Maurizio, et al.
Publicado: (2018)

Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome
por: Schleifer, Grigorij, et al.
Publicado: (2019)

Inhibition of ornithine decarboxylase restores hypoxic pulmonary vasoconstriction in endotoxemic mice
por: Gebauer, P.H., et al.
Publicado: (2020)

The hypoxic pulmonary vasoconstriction: From physiology to clinical application in thoracic surgery
por: Licker, Marc, et al.
Publicado: (2021)

Imaging Depiction of Hypoxic Pulmonary Vasoconstriction Using Dual-Energy CT
por: Hunter, Joshua G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pb7btbs7srmmoa9c013p2qr3gs